strategynet.ai
strategynet.ai — Insights
How StrategyNet turns signals into portfolios · Published 2026-07-14
Workflow

How StrategyNet turns signals into portfolios

The path from a market observation to a portfolio is not one model call. It is a chain of distinct research objects, each with its own timing rules and its own test. A feature becomes a signal; a signal becomes a factor-mimicking portfolio; validated FMPs become sleeves in a final allocation. Keeping those objects separate is what makes the process inspectable.

This series follows that chain in four short animations. The written notes fill in the definitions and mathematics that move too quickly on screen.

Stage 1Constructfeatures → signal → pure FMP
Stage 2Projectlive evidence → stock ranks
Stage 3Validatewalk-forward tests → ordered sleeves
Stage 4Allocateselected FMPs → final portfolio

The objects that pass between stages

A feature is a measured value for one security at one time. A signal is a cross-sectional forecast: it says how securities rank relative to one another. An FMP is different again. It is a vector of security weights built to preserve exposure to one signal while removing unwanted market, sector, or style exposures.

Once that FMP is held through time, it produces a return history. Only then can it be treated as a sleeve, tested out of sample, compared with other sleeves, and considered for allocation. The final portfolio is therefore not a larger factor score. It is a constrained combination of already constructed and validated portfolios.

The same risk model appears twice for a reason. It defines the geometry used to purify individual FMPs, and later maps the selected FMP combination back to a consistent asset-level optimization problem. The four pages show where that continuity enters the process.

This walkthrough is for research and educational purposes. It illustrates how strategynet.ai organizes signal evidence into factors and scenarios. It provides no recommendation, investment advice, or instruction to trade any security.

Back to Insights